Scott A. Kono

1.9k total citations
22 papers, 1.4k citations indexed

About

Scott A. Kono is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Scott A. Kono has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Scott A. Kono's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Head and Neck Cancer Studies (4 papers). Scott A. Kono is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Head and Neck Cancer Studies (4 papers). Scott A. Kono collaborates with scholars based in United States, Switzerland and India. Scott A. Kono's co-authors include Robert C. Doebele, D. Ross Camidge, Nabil F. Saba, Fadlo R. Khuri, Dong M. Shin, Marileila Varella‐Garcia, Wilbur A. Franklin, Jonathan J. Beitler, Taofeek K. Owonikoko and Amy Y. Chen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Scott A. Kono

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott A. Kono United States 15 815 674 485 375 250 22 1.4k
J.L. Geiger United States 16 681 0.8× 243 0.4× 469 1.0× 235 0.6× 526 2.1× 92 1.3k
L.L. Siu Canada 10 833 1.0× 290 0.4× 247 0.5× 248 0.7× 54 0.2× 30 1.1k
Cherie Perez United States 9 314 0.4× 198 0.3× 137 0.3× 419 1.1× 128 0.5× 16 955
X. Montbarbon France 16 368 0.5× 308 0.5× 412 0.8× 68 0.2× 282 1.1× 40 1.3k
William H. Liggett United States 10 588 0.7× 411 0.6× 118 0.2× 522 1.4× 273 1.1× 16 1.2k
Preston D. Steen United States 18 579 0.7× 329 0.5× 120 0.2× 259 0.7× 38 0.2× 47 1.0k
A. Psyrri Greece 9 300 0.4× 193 0.3× 197 0.4× 186 0.5× 225 0.9× 23 814
Antonio Jirillo Italy 15 595 0.7× 307 0.5× 424 0.9× 137 0.4× 456 1.8× 60 1.1k
Cheng‐Lung Hsu Taiwan 18 364 0.4× 209 0.3× 178 0.4× 187 0.5× 348 1.4× 46 881
George Zarkavelis Greece 15 458 0.6× 170 0.3× 126 0.3× 169 0.5× 25 0.1× 52 813

Countries citing papers authored by Scott A. Kono

Since Specialization
Citations

This map shows the geographic impact of Scott A. Kono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Kono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Kono more than expected).

Fields of papers citing papers by Scott A. Kono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Kono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Kono. The network helps show where Scott A. Kono may publish in the future.

Co-authorship network of co-authors of Scott A. Kono

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Kono. A scholar is included among the top collaborators of Scott A. Kono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Kono. Scott A. Kono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leal, Alexis D., Patrick J. Blatchford, Robert W. Lentz, et al.. (2025). Phase II study of cabozantinib and nivolumab in refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC).. Journal of Clinical Oncology. 43(4_suppl). 229–229. 1 indexed citations
2.
Kono, Scott A., et al.. (2021). Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System. BioDrugs. 36(1). 1–11. 7 indexed citations
3.
Singer, Michael C., Edward Peterson, Heather Spencer Feigelson, et al.. (2015). Socioeconomic Factors Affect Outcomes in Well‐Differentiated Thyroid Cancer. Otolaryngology. 154(3). 440–445. 15 indexed citations
4.
Shin, Dong M., Hongzheng Zhang, Nabil F. Saba, et al.. (2013). Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies. Clinical Cancer Research. 19(5). 1244–1256. 49 indexed citations
5.
Ramalingam, Suresh S., Taofeek K. Owonikoko, Madhusmita Behera, et al.. (2013). Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(3). 369–372. 32 indexed citations
6.
Kono, Scott A., et al.. (2013). Patients' perceptions of Complementary and Alternative Medicine in head and neck cancer: A qualitative, pilot study with clinical implications. Complementary Therapies in Clinical Practice. 20(4). 213–218. 12 indexed citations
7.
Saba, Nabil F., Scott A. Kono, Selwyn J. Hurwitz, et al.. (2013). Carboplatin (C), cetuximab (Cet), and everolimus (E) in recurrent or metastatic squamous cell carcinoma of the head and neck (RMSCCHN). Results of a phase Ib study.. Journal of Clinical Oncology. 31(15_suppl). 6083–6083. 2 indexed citations
8.
Goodman, Michael, Scott A. Kono, William Grist, et al.. (2012). Adenoid cystic carcinoma of the head and neck. Cancer. 118(18). 4444–4451. 261 indexed citations
9.
Müller, Susan, Fadlo R. Khuri, Scott A. Kono, et al.. (2012). HPV Positive Squamous Cell Carcinoma of the Oropharynx. Are we Observing an Unusual Pattern of Metastases?. Head and Neck Pathology. 6(3). 336–344. 54 indexed citations
10.
Kono, Scott A., Lynn E. Heasley, Robert C. Doebele, & D. Ross Camidge. (2012). Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer. Current Cancer Drug Targets. 12(2). 107–123. 48 indexed citations
11.
Kono, Scott A., Missak Haigentz, Sue S. Yom, & Nabil F. Saba. (2012). EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. PubMed. 2012. 1–10. 10 indexed citations
12.
Behera, Madhusmita, Taofeek K. Owonikoko, Zhengjia Chen, et al.. (2012). Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis. Lung Cancer. 77(2). 331–338. 39 indexed citations
13.
Shaib, Walid L., Scott A. Kono, & Nabil F. Saba. (2012). Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck. Journal of Oncology. 2012. 1–11. 14 indexed citations
14.
Camidge, D. Ross, Scott A. Kono, Xian Lu, et al.. (2011). Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed. Journal of Thoracic Oncology. 6(4). 774–780. 195 indexed citations
15.
Hinz, Trista K., Scott A. Kono, Katherine R. Singleton, et al.. (2011). Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells. Clinical Cancer Research. 17(15). 5016–5025. 84 indexed citations
16.
Kono, Scott A., et al.. (2011). Adenoid cystic carcinoma of the head and neck (ACCHN) incidence and survival trends.. Journal of Clinical Oncology. 29(15_suppl). 5580–5580.
17.
Behera, Madhusmita, Taofeek K. Owonikoko, Scott A. Kono, et al.. (2011). Single-agent maintenance therapy for advanced-stage non-small cell lung cancer: A meta-analysis.. Journal of Clinical Oncology. 29(15_suppl). 7553–7553. 4 indexed citations
18.
Camidge, D. Ross, Scott A. Kono, Antonella Flacco, et al.. (2010). Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment. Clinical Cancer Research. 16(22). 5581–5590. 264 indexed citations
19.
20.
Kono, Scott A., et al.. (2007). Contemporary Empyema Necessitatis. The American Journal of Medicine. 120(4). 303–305. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.L. Geiger Breakdown of academic impact, for papers by L.L. Siu Breakdown of academic impact, for papers by Cherie Perez Breakdown of academic impact, for papers by X. Montbarbon Breakdown of academic impact, for papers by William H. Liggett Breakdown of academic impact, for papers by Preston D. Steen Breakdown of academic impact, for papers by A. Psyrri Breakdown of academic impact, for papers by Antonio Jirillo Breakdown of academic impact, for papers by Cheng‐Lung Hsu Breakdown of academic impact, for papers by George Zarkavelis
Rankless by CCL
2026